| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | Director | Common Stock | 16K | $79.2K | $4.95 | 05 Jun 2024 | Direct |
| Syros Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6K | 05 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals, Inc. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 16:30 |
| SYRS | Syros Pharmaceuticals, Inc. | 01 Jun 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 16:25 |
| SYRS | Syros Pharmaceuticals, Inc. | 16 Sep 2022 | 2 | $0 | 4 | Director | 19 Sep 2022, 17:14 |
| SYRS | Syros Pharmaceuticals, Inc. | 16 Sep 2022 | 0 | $0 | 3 | Director | 19 Sep 2022, 17:06 |